bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.07.03.601810

Dicarbonyl stress enhances tumor intravasation

Abstract

Metastasis of cancer is a multi-step process that involves the migration of transformed cells from their native organ into a vascular channel, followed by their dissemination to prospective sites of colonization. The entry of tumor cells into blood or lymph, known as intravasation involves their breaching the stromal and endothelial extracellular matrix (ECM) and the endothelial barriers. How the kinetics of these cell-ECM interactions are confounded by chronic inflammatory stresses seen in comorbid risk factors of cancer such as diabetes and aging remain ill-investigated. Here, we construct and deploy a histopathology-motivated, imaging-tractable, microfluidic multi-organ-on-chip platform, that seamlessly integrates two tissue environments: that of a breast tumor and a vascular channel, to study the problem. The former comprises invasive triple-negative MDA-MB-231 breast cancer cells embedded within a three-dimensional fibrillar Collagen I milieu. The latter consists of a monolayer of TeloHAEC, immortalized human aortic endothelial cells arranged on laminin-rich basement membrane ECM, both of which concentrically line a hollow channel, wherein unidirectional fluid flows are implemented. The chip showcases the complexity of intravasation, wherein tumor cells and endothelia cooperate to form anastomotic structures. The formation of such structures is regulated by fluid flow in the vascular channel and is associated with cancer cell migration and entry into the vascular channel. Disseminated cancer cells are observed to enter, get adhered within, and flow through the vascular channel. Exposure to methylglyoxal (MG), a mediator of dicarbonyl stress associated with diabetic circulatory milieu, leads to greater cancer cell intravasation and flow through the vascular channel. This could be driven not just by MG-induced endothelial senescence and shedding, but also by the effect of MG on the chip ECM: we demonstrate it can degrade basement membrane and pathologically crosslink Collagen I, diminishing their cell adhesiveness. Our results thus show how dicarbonyl stress may attenuate homoeostatic barriers to cancer intravasation, exacerbating metastasis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kumar, N., Samanta, B., M, J. K., Raghunathan, V., Sen, P., Bhat, R.. 2024-07-05. Dicarbonyl stress enhances tumor intravasation. https://doi.org/10.1101/2024.07.03.601810

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Comparative study of chlorophyll measurement in Physcomitrium patens moss using a conventional microscope adapted for combined 2D+1D imaging and spectral analysis

Imaging spectroscopy often requires expensive and complex equipment. Here we show a simple procedure for attaching a standard miniature fiber spectrometer to a conventional microscope, allowing easy integration of 2D imaging with 1D high-resolution spectral measurements. This combination provides much of the benefit of a full imaging spectrometer without the large equipment investment, and we provide instructions for modifying microscopes to this setup and the present measurements of living cells that demonstrate their performance. Using this setup, we compare the quantitative measurement of chlorophyll concentration in Physcomitrium patens moss using color imaging and spectral sampling.

bioengineering↗

De novo designed single-domain antibodies protect against lethal cobra venom neurotoxicity in vivo

Generative protein design can now rapidly produce de novo binders with high affinity and functional activity against a wide range of targets, including lethal snake venom toxins. However, so far most reported successes rely on new-to-nature scaffolds with limited therapeutic precedent. Single-domain antibodies (VHHs) offer a clinically validated alternative scaffold that can bind and neutralize long-chain -neurotoxins, which are some of the most lethal components in snake venoms. Here we compare three recently established de novo design models with VHH-design capabilities (Germinal, RFantibody, and BoltzGen) for their ability to generate VHHs against the neurotoxin -cobratoxin from the monocled cobra (Naja kaouthia). Using standardized model inputs and evaluation criteria based on AlphaFold3 interface confidence (ipTM) and RMSD self-consistency, we find that Germinal was the only method to generate designs passing stringent in silico criteria for experimental testing. We therefore performed a larger Germinal design campaign employing three different VHH frameworks and experimentally validated 46 designs in vitro. Of these, 42 expressed as soluble proteins and we identified four binding hits derived from two of the three tested frameworks. Of the four binders, two lead candidates were further characterized and demonstrated high affinity (KDs of 4.1 nM and 10.8 nM), monomeric behavior and low polyreactivity, indicating favorable biophysical and developability properties, as well as functional toxin neutralization in vitro. To assess their therapeutic potential we investigated their ability to protect against -cobratoxin toxicity in vivo. Both candidates fully protected mice after -cobratoxin challenge, with 100% survival compared to a lethal control. One candidate also retained notable neutralization capacity against whole venom of Naja kaouthia with a survival of 56%, while the other protected 22% when tested in a rescue setting. Together, we demonstrate that de novo VHH design can generate high affinity single-domain antibodies with in vivo protection against lethal cobra venom neurotoxicity, and provide practical insights into method- and framework-dependent performance.

bioengineering↗

Simple Feedback for Complex Movement: Capturing Whole-Limb Reorganization during Single-IMU Gait Retraining

Clinical gait retraining typically relies on multi-sensor arrays and high-dimensional feedback displays, imposing setup and interpretation burdens that limit routine clinical deployment. We developed a single-IMU visual biofeedback system that delivers real-time feedback of Lower Limb Trajectory Error (LLTE), a composite kinematic error metric integrating knee position and shank angle across the stance phase. Twenty able-bodied adults walked on a treadmill under two visual biofeedback targets (flexed-knee, extended-knee) while receiving either corrected (n=10) or uncorrected (n=8) feedback, where the correction accounted for limb orientation at initial contact. LLTE and stance-phase knee kinematics adapted consistently under the flexed-knee target for both feedback groups, with feedback formulation moderating the temporal trajectory of change. Adaptation toward the extended-knee target was limited, likely because participants were already operating near terminal knee extension and because the scalar error metric provided limited directional information for correction. Ankle range of motion (ROM) changed significantly across the stance phase under both target conditions, while hip ROM did not. Multiscale multivariate sample entropy (MSMVSE) increased monotonically with time scale across all conditions, with no statistically distinguishable difference between corrected and uncorrected feedback. These results suggest that single-IMU LLTE biofeedback can modify gait mechanics and that adaptation was expressed across multiple lower-limb segments rather than through changes at a single joint.

bioengineering↗